Advanced Molecular Detection (AMD) and Response to Infectious Disease Outbreaks

Related Pages

Advanced molecular detection (AMD) integrates the latest next-generation genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation to help us find, track, and stop disease-causing pathogens faster than ever before.

Two lab scientists preparing vials for sequencing using a large machine
Who We Are
Scientist identifying pathogens on a computer screen.
What We Do
Closeup of a flow cell for an Illumina sequencing machine held by hands in blue gloves. The scientist's face can be seen in the background.
What's New
A scientist working with samples in a lab.
How it Works
What's New
NGS Quality Initiative releases new tools

Posted on Friday, July 31, 2020

The CDC and APHL Next Generation Sequencing (NGS) Quality Initiative released the next set of ready-to-implement tools and documents. Adding to the collection of documents for Illumina Miseq, Oxford Nanopore’s MinION, and ThermoFisher’s Ion Torrent, this set of products includes SOPs for training personnel on Illumina’s MiniSeq and NextSeq. Additionally, this set provides tools and documents for two new Quality System Essentials (QSEs):  Information Management and Assessment. Within this release are documents on best practices for documenting bioinformatic pipelines to support reproducibility under the Information Management QSE. This release also contains documents on identifying, developing, and applying key performance indicators to your sequencing assays and a Quality Management System Internal Assessment Tool to help laboratories assess compliance with quality system recommendations under the Assessment QSE.

Read more on What's New page
Resources
illustration of PulseNet scientists with a background that symbolizes the transition from PFGE technology to whole genome sequencing technology
Follow us @CDC_AMD
Related Links

Page last reviewed: July 31, 2020
Content source: Centers for Disease Control and Prevention